As is the case with the discovery of all novel variants, consideration of pseudocontrol human population gene frequency, conservation in orthologs through evolution, pathogenicity prediction, and biological context was necessary to establish how TNIP2 and TRAF2 were involved in PAH. The gene discussed is TRAF2; the disease is pulmonary arterial hypertension.